1
|
Fardon DF, Williams AL, Dohring EJ,
Murtagh FR, Gabriel Rothman SL and Sze GK: Lumbar disc
nomenclature: Version 2.0: Recommendations of the combined task
forces of the North American Spine Society, the American Society of
Spine Radiology, and the American Society of Neuroradiology. Spine
J. 14:2525–2545. 2014.PubMed/NCBI View Article : Google Scholar
|
2
|
Hemanta D, Jiang XX, Feng ZZ, Chen ZX and
Cao YW: Etiology for Degenerative Disc Disease. Chin Med Sci J.
31:185–191. 2016.PubMed/NCBI View Article : Google Scholar
|
3
|
Lu H and Peng L: Efficacy and safety of
Mobi-C cervical artificial disc versus anterior discectomy and
fusion in patients with symptomatic degenerative disc disease: A
meta-analysis. Medicine (Baltimore). 96(e8504)2017.PubMed/NCBI View Article : Google Scholar
|
4
|
Matta A, Karim MZ, Isenman DE and Erwin
WM: Molecular therapy for degenerative disc disease: Clues from
secretome analysis of the notochordal cell-rich nucleus pulposus.
Sci Rep. 7(45623)2017.PubMed/NCBI View Article : Google Scholar
|
5
|
Liang L, Li X, Li D, Jiang W, Wang H, Chen
J, Sun Z, Zhang N and Zhu Y: The characteristics of stem cells in
human degenerative intervertebral disc. Medicine (Baltimore).
96(e7178)2017.PubMed/NCBI View Article : Google Scholar
|
6
|
Guo J, Shao M, Lu F, Jiang J and Xia X:
Role of Sirt1 plays in nucleus pulposus cells and intervertebral
disc degeneration. Spine (Phila Pa 1976). 42:E757–E766.
2017.PubMed/NCBI View Article : Google Scholar
|
7
|
Vedicherla S and Buckley CT: Cell-based
therapies for intervertebral disc and cartilage regeneration -
Current concepts, parallels, and perspectives. J Orthop Res.
35:8–22. 2017.PubMed/NCBI View Article : Google Scholar
|
8
|
Skovrlj B, Cunn G, Guzman JZ and Qureshi
SA: Mesenchymal stem cell technology in the treatment of
degenerative disc disease. J Neurosurg Sci. 59:25–35.
2015.PubMed/NCBI
|
9
|
Centeno C, Markle J, Dodson E, Stemper I,
Williams CJ, Hyzy M, Ichim T and Freeman M: Treatment of lumbar
degenerative disc disease-associated radicular pain with
culture-expanded autologous mesenchymal stem cells: A pilot study
on safety and efficacy. J Transl Med. 15(197)2017.PubMed/NCBI View Article : Google Scholar
|
10
|
Li XC, Tang Y, Wu JH, Yang PS, Wang DL and
Ruan DK: Characteristics and potentials of stem cells derived from
human degenerated nucleus pulposus: Potential for regeneration of
the intervertebral disc. BMC Musculoskelet Disord.
18(242)2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Zhang S, Chen A, Hu W, Li M, Liao H, Zhu
W, Song D and Guo F: Immunological purification of rat
precartilaginous stem cells and construction of the immortalized
cell strain. Arch Orthop Trauma Surg. 128:1339–1344.
2008.PubMed/NCBI View Article : Google Scholar
|
12
|
Li C, Wang Q and Wang JF: Transforming
growth factor-β (TGF-β) induces the expression of
chondrogenesis-related genes through TGF-β receptor II
(TGFRII)-AKT-mTOR signaling in primary cultured mouse
precartilaginous stem cells. Biochem Biophys Res Commun.
450:646–651. 2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Fan MP, Si M, Li BJ, Hu GH, Hou Y, Yang W,
Liu L, Tang B and Nie L: Cell therapy of a knee osteoarthritis rat
model using precartilaginous stem cells. Eur Rev Med Pharmacol Sci.
22:2119–2125. 2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Richardson SM, Kalamegam G, Pushparaj PN,
Matta C, Memic A, Khademhosseini A, Mobasheri R, Poletti FL,
Hoyland JA and Mobasheri A: Mesenchymal stem cells in regenerative
medicine: Focus on articular cartilage and intervertebral disc
regeneration. Methods. 99:69–80. 2016.PubMed/NCBI View Article : Google Scholar
|
15
|
Xia K, Gong Z, Zhu J, Yu W, Wang Y, Wang
J, Xu A, Zhou X, Tao H, Li F and Liang C: Differentiation of
pluripotent stem cells into nucleus pulposus progenitor cells for
intervertebral disc regeneration. Curr Stem Cell Res Ther.
14:57–64. 2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Chen P, Ning L, Qiu P, Mo J, Mei S, Xia C,
Zhang J, Lin X and Fan S: Photo-crosslinked gelatin-hyaluronic acid
methacrylate hydrogel-committed nucleus pulposus-like
differentiation of adipose stromal cells for intervertebral disc
repair. J Tissue Eng Regen Med. 13:682–693. 2019.PubMed/NCBI View Article : Google Scholar
|
17
|
Ma K, Chen S, Li Z, Deng X, Huang D, Xiong
L and Shao Z: Mechanisms of endogenous repair failure during
intervertebral disc degeneration. Osteoarthritis Cartilage.
27:41–48. 2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Yang Z, Gao XJ and Zhao X: CDMP1 promotes
type II collagen and aggrecan synthesis of nucleus pulposus cell
via the mediation of ALK6. Eur Rev Med Pharmacol Sci.
24:10975–10983. 2020.PubMed/NCBI View Article : Google Scholar
|
19
|
Le Maitre CL, Pockert A, Buttle DJ,
Freemont AJ and Hoyland JA: Matrix synthesis and degradation in
human intervertebral disc degeneration. Biochem Soc Trans.
35:652–655. 2007.PubMed/NCBI View Article : Google Scholar
|
20
|
Yang SH, Wu CC, Shih TT, Sun YH and Lin
FH: In vitro study on interaction between human nucleus pulposus
cells and mesenchymal stem cells through paracrine stimulation.
Spine (Phila Pa 1976). 33:1951–1957. 2008.PubMed/NCBI View Article : Google Scholar
|
21
|
Wang Q, Gu X, Cheng L and Wang J:
Differentiation of immortalized human precartilaginous stem cells
into nucleus pulposus-like cells. Int J Clin Exp Pathol.
8:2816–2822. 2015.PubMed/NCBI
|
22
|
Saliminejad K, Khorram Khorshid HR,
Soleymani Fard S and Ghaffari SH: An overview of microRNAs:
Biology, functions, therapeutics, and analysis methods. J Cell
Physiol. 234:5451–5465. 2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Wang C, Wang WJ, Yan YG, Xiang YX, Zhang
J, Tang ZH and Jiang ZS: MicroRNAs: New players in intervertebral
disc degeneration. Clin Chim Acta. 450:333–341. 2015.PubMed/NCBI View Article : Google Scholar
|
24
|
Wang Q, Gu X and Wang J: Transforming
growth factor-β1 (TGF-β1) induces mouse precartilaginous stem cell
differentiation through TGFRII-CK1ε-β-catenin signalling. Int J Exp
Pathol. 99:113–120. 2018.PubMed/NCBI View Article : Google Scholar
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
26
|
Zhou X, Tao Y, Chen E, Wang J, Fang W,
Zhao T, Liang C, Li F and Chen Q: Genipin-cross-linked type II
collagen scaffold promotes the differentiation of adipose-derived
stem cells into nucleus pulposus-like cells. J Biomed Mater Res A.
106:1258–1268. 2018.PubMed/NCBI View Article : Google Scholar
|
27
|
Vishnoi A and Rani S: miRNA biogenesis and
regulation of diseases: An overview. Methods Mol Biol. 1509:1–10.
2017.PubMed/NCBI View Article : Google Scholar
|
28
|
Weber KT, Jacobsen TD, Maidhof R,
Virojanapa J, Overby C, Bloom O, Quraishi S, Levine M and Chahine
NO: Developments in intervertebral disc disease research:
Pathophysiology, mechanobiology, and therapeutics. Curr Rev
Musculoskelet Med. 8:18–31. 2015.PubMed/NCBI View Article : Google Scholar
|
29
|
Kang Q, Xiang Y, Li D, Liang J, Zhang X,
Zhou F, Qiao M, Nie Y, He Y, Cheng J, et al: miR-124-3p attenuates
hyperphosphorylation of Tau protein-induced apoptosis via
caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells.
Oncotarget. 8:24314–24326. 2017.PubMed/NCBI View Article : Google Scholar
|
30
|
Zo RB and Long Z: miR-124-3p suppresses
bladder cancer by targeting DNA methyltransferase 3B. J Cell
Physiol. 234:464–474. 2018.PubMed/NCBI View Article : Google Scholar
|
31
|
Long HD, Ma YS, Yang HQ, Xue SB, Liu JB,
Yu F, Lv ZW, Li JY, Xie RT, Chang ZY, et al: Reduced hsa-miR-124-3p
levels are associated with the poor survival of patients with
hepatocellular carcinoma. Mol Biol Rep. 45:2615–2623.
2018.PubMed/NCBI View Article : Google Scholar
|
32
|
Luo L, Chi H and Ling J: miR-124-3p
suppresses glioma aggressiveness via targeting of Fra-2. Pathol Res
Pract. 214:1825–1834. 2018.PubMed/NCBI View Article : Google Scholar
|
33
|
Zhang Y, Liu HL, An LJ, Li L, Wei M, Ge DJ
and Su Z: miR-124-3p attenuates neuropathic pain induced by chronic
sciatic nerve injury in rats via targeting EZH2. J Cell Biochem.
120:5747–5755. 2019.PubMed/NCBI View Article : Google Scholar
|
34
|
Tao Y, Zhou X, Liu D, Li H, Liang C, Li F
and Chen Q: Proportion of collagen type II in the extracellular
matrix promotes the differentiation of human adipose-derived
mesenchymal stem cells into nucleus pulposus cells. Biofactors.
42:212–223. 2016.PubMed/NCBI View Article : Google Scholar
|
35
|
Lian C, Gao B, Wu Z, Qiu X, Peng Y, Liang
A, Xu C, Su P and Huang D: Collagen type II is downregulated in the
degenerative nucleus pulposus and contributes to the degeneration
and apoptosis of human nucleus pulposus cells. Mol Med Rep.
16:4730–4736. 2017.PubMed/NCBI View Article : Google Scholar
|
36
|
Shibanuma M, Mashimo J, Mita A, Kuroki T
and Nose K: Cloning from a mouse osteoblastic cell line of a set of
transforming-growth-factor-beta 1-regulated genes, one of which
seems to encode a follistatin-related polypeptide. Eur J Biochem.
217:13–19. 1993.PubMed/NCBI View Article : Google Scholar
|
37
|
Ogura Y, Ouchi N, Ohashi K, Shibata R,
Kataoka Y, Kambara T, Kito T, Maruyama S, Yuasa D, Matsuo K, et al:
Therapeutic impact of follistatin-like 1 on myocardial ischemic
injury in preclinical models. Circulation. 126:1728–1738.
2012.PubMed/NCBI View Article : Google Scholar
|
38
|
Torres S, Bartolomé RA, Mendes M, Barderas
R, Fernandez-Aceñero MJ, Peláez-García A, Peña C, Lopez-Lucendo M,
Villar-Vázquez R, de Herreros AG, et al: Proteome profiling of
cancer-associated fibroblasts identifies novel proinflammatory
signatures and prognostic markers for colorectal cancer. Clin
Cancer Res. 19:6006–6019. 2013.PubMed/NCBI View Article : Google Scholar
|
39
|
Wilson DC, Marinov AD, Blair HC, Bushnell
DS, Thompson SD, Chaly Y and Hirsch R: Follistatin-like protein 1
is a mesenchyme-derived inflammatory protein and may represent a
biomarker for systemic-onset juvenile rheumatoid arthritis.
Arthritis Rheumatism. 62:2510–2516. 2010.PubMed/NCBI View Article : Google Scholar
|
40
|
Liu Y, Wei J, Zhao Y, Zhang Y, Han Y, Chen
B, Cheng K, Jia J, Nie L and Cheng L: Follistatin-like protein 1
promotes inflammatory reactions in nucleus pulposus cells by
interacting with the MAPK and NFκB signaling pathways. Oncotarget.
8:43023–43034. 2017.PubMed/NCBI View Article : Google Scholar
|